908 Devices (MASS) Reiterated at Buy by Stifel: US Policy, Macro Drive Demand

Stifel analyst Daniel Arias reiterated a Buy rating and $8.00 price target on 908 Devices Inc. (NASDAQ: MASS).

The analyst commented, "MASS saw solid growth across the portfolio, with good execution on operational priorities, even if GMs did come in a bit light vs. our number. The company remains arguably the one name in our coverage where US policy decisions and macro-level developments stand as drivers of product demand. While federal project work can carry timing risk, this does not appear to be an issue (AVCAD is on track) - and along the way state and local government contributions are growing in size (43% on revenues) and at a healthy clip (38% growth last year). As such, we continue to see tailwinds ahead - and while some additional investments will affect quarterly profitability in 2026, we are cautiously optimistic that the 2027 view can include full-year EBITDA positivity. In our view, MASS remains a good name for the small cap investor interested in life sciences (adjacent) markets."

For an analyst ratings summary and ratings history on 908 Devices Inc. click here. For more ratings news on 908 Devices Inc. click here.

Shares of 908 Devices Inc. closed at $6.32 yesterday.

You May Also Be Interested In

• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'
• Brean Capital Upgrades Columbia Financial Inc (CLBK) to Buy
• JPMorgan Downgrades EyePoint Inc. (EYPT) to Neutral